Quantcast

PharmaNet Experts to Showcase Bioanalytical Posters at ASMS 2011

May 23, 2011

PRINCETON, N.J., May 23, 2011 /PRNewswire/ — PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that its experts will be sharing a range of innovative bioanalysis solutions, including high resolution mass spectrometry applications, at the ASMS 59th Conference on Mass Spectrometry and Allied Topics in Denver, Colorado from June 5 to June 9. PharmaNet’s scientists welcome you to attend their poster sessions throughout the conference.


    Tuesday June 7
    --------------

    Poster 255: On-Cartridge Derivatization for the Determination of
     Bisphosphonates in Human Urine
    Authors: Nicolas Jean, Sylvain Lachance, Nadine Boudreau, Sofi
     Gagnon-Carignan, Ann Levesque

    Poster 277: Stability issues and method development of a polar
     phenolic quaternary amine compound in human plasma by LC/MS/MS
    Authors: Valerie Montminy, Nicolas Piquet, Sylvain Lachance, Nadine
     Boudreau; Ann Levesque

    Poster 257: Using ICP-MS Detection for Determination of Bismuth in
     Human Blood and Plasma Samples
    Authors: Nadia Savard, Sebastien Gagne, Francois Viel, Brigitte
     Pellerin, Nadine Boudreau

    Poster 258: High Throughput Analysis of Biological Samples Containing
     Trace Metals with Limited Down Time by ICP-MS
    Authors: Sebastien Gagne, Francois Viel, Nadine Boudreau, Sylvain
     Lachance, Sofi Gagnon-Carignan, Ann Levesque

    Poster 267: Development and Validation of a Dried Blood Spot Assay
     for the Determination of Midazolam in Human Whole Blood by LC/MS/
     MS
    Authors: Guy Havard, Marie-Claude Theberge, Nadine Boudreau, Ann
     Levesque

    Poster 273: Ultra Low Picograms Determination of a Glucocorticoid in
     Human Plasma
    Authors: Nadia Smith, Nicolas Jean, Nathalie Pelletier, Sylvain
     Lachance, Nadine Boudreau, Ann Levesque

    Poster 272: An Ultrasensitive LC/MS/MS Method for the Determination
     of Formoterol in Human Plasma at Femtogram Level
    Authors: Isabelle M. Levesque, Francois Viel, Sylvain Lachance,
     Nadine Boudreau, Ann Levesque

    Poster 271: Evaluation of Hemolysis Effect during Sample Collection
     and Handling to Mimic Incurred Samples during LC/MS/MS Method
     Validation
    Authors: Sebastien Gagne, Sylvain Lachance, Nadine Boudreau, Ann
     Levesque

    Poster 268: Analyte and Internal Standard Cross Signal Contributions
     in Mass Spectrometric Detection and Their Impact on the Quantitation
     by LC/MS
    Authors: Aimin Tan, Isabelle A. Levesque, Isabelle M. Levesque,
     Francois Viel, Nadine Boudreau, Ann Levesque

    Poster 269: A Novel Automated LC/MS/MS Method for the Simultaneous
     Determination of Levothyroxine (T4) and Liothyronine (T3) in Human
     Serum
    Authors: Gilles Provencher, Francois Viel, Nadine Boudreau, Ann
     Levesque

    Poster 270: LC/MS/MS Analysis of Doxercalciferol and its Main
     Metabilite in Human Plasma at Low Picogram Level
    Authors: Guy Havard, Sylvain Lachance, Nadine Boudreau, Ann Levesque

    Wednesday June 8
    ----------------

    Poster 146: A Robust and Selective Method for Two Omega-3 Fatty
     Acids (Eicosapentanoic Acid and Docosahexaenoic Acid) in Several
     Matrix Species
    Authors: Guy Havard, Nathalie Pelletier, Sylvain Lachance, Nadine
     Boudreau, Ann Levesque, Farhad Amiri, Bruno Battistini, Tina
     Sampalis

    Thursday June 9
    ---------------

    Poster 469: Determination of Polypeptides and other Large Molecular
     Weight Molecules by LC/MS/MS
    Authors: Genevieve Emond, Nadia Savard, Simon Bedard, Philippe
     Belanger, Nancy Lampron, Nathalie Pelletier, Marie-Josee Marcoux,
     Sylvain Lachance, Nadine Boudreau, Ann Levesque

About PharmaNet

PharmaNet Development Group, Inc., a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit www.PharmaNet.com.

Contact: Anne-Marie Hess
Phone: (609) 951-6842
E-mail: ahess@pharmanet.com

SOURCE PharmaNet Development Group, Inc.


Source: newswire



comments powered by Disqus